SG11202010857TA - Preparation method for rejuvenated regenerative fibroblast and application thereof - Google Patents
Preparation method for rejuvenated regenerative fibroblast and application thereofInfo
- Publication number
- SG11202010857TA SG11202010857TA SG11202010857TA SG11202010857TA SG11202010857TA SG 11202010857T A SG11202010857T A SG 11202010857TA SG 11202010857T A SG11202010857T A SG 11202010857TA SG 11202010857T A SG11202010857T A SG 11202010857TA SG 11202010857T A SG11202010857T A SG 11202010857TA
- Authority
- SG
- Singapore
- Prior art keywords
- rejuvenated
- preparation
- application
- fibroblast
- regenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides, bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/03—Compounds acting on the NO pathway, e.g. nitrososarginine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/065—Modulators of histone acetylation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/405—Cell cycle regulated proteins, e.g. cyclins, cyclin-dependant kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/42—Notch; Delta; Jagged; Serrate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810407290.XA CN110423721B (zh) | 2018-05-01 | 2018-05-01 | 一种年轻化的修复型成纤维细胞的制备方法及其应用 |
PCT/CN2019/085401 WO2019210870A1 (fr) | 2018-05-01 | 2019-05-01 | Procédé de préparation de fibroblaste régénérateur régénéré et son application |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202010857TA true SG11202010857TA (en) | 2021-02-25 |
Family
ID=68387001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202010857TA SG11202010857TA (en) | 2018-05-01 | 2019-05-01 | Preparation method for rejuvenated regenerative fibroblast and application thereof |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210213069A1 (fr) |
EP (1) | EP3789484A4 (fr) |
JP (1) | JP2021523734A (fr) |
CN (1) | CN110423721B (fr) |
AU (1) | AU2019263866B2 (fr) |
CA (1) | CA3098938C (fr) |
SG (1) | SG11202010857TA (fr) |
WO (1) | WO2019210870A1 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117887659A (zh) * | 2018-05-01 | 2024-04-16 | 云南济慈再生医学研究院有限公司 | 一种促进靶细胞向神经细胞分化的方法 |
CN110423721B (zh) * | 2018-05-01 | 2024-02-27 | 云南济慈再生医学研究院有限公司 | 一种年轻化的修复型成纤维细胞的制备方法及其应用 |
US20210230551A1 (en) * | 2018-05-04 | 2021-07-29 | Spinalcyte, Llc | Enhancement of fibroblast plasticity for treatment of disc degeneration |
CN111166769B (zh) * | 2020-03-18 | 2022-01-11 | 山东大学 | 真皮成纤维细胞在治疗黑色素瘤中的应用 |
CN112143749B (zh) * | 2020-08-27 | 2023-05-12 | 北京宝易生物技术有限公司 | 一种长效重组犬干扰素制品及制备方法和应用 |
CN112430626A (zh) * | 2020-11-27 | 2021-03-02 | 成都康景生物科技有限公司 | 一种基因修饰的脐间充质干细胞、制备方法及应用 |
CN112725437B (zh) * | 2021-02-02 | 2022-12-06 | 暨南大学 | 节律基因蛋白表达和rna甲基化修饰在制备衰老检测试剂盒中的应用 |
CN113278619B (zh) * | 2021-07-19 | 2021-10-15 | 广东省农业科学院动物科学研究所 | 双sgRNA、基因敲除载体、基因敲除STING基因的猪成纤维细胞系及其构建方法 |
CN113893337A (zh) * | 2021-08-31 | 2022-01-07 | 中山大学 | Dtx2蛋白在制备调控端粒酶活性的制剂中的应用 |
CN115975944A (zh) * | 2021-10-14 | 2023-04-18 | 北京干细胞与再生医学研究院 | 年轻化非多能性细胞及其制备方法和应用 |
CN114381461B (zh) * | 2022-03-24 | 2022-07-19 | 中国人民解放军军事科学院军事医学研究院 | 一种通过清除野生型p53蛋白促进ATG5-ATG12共轭增强细胞自噬的应用 |
WO2023200223A1 (fr) * | 2022-04-15 | 2023-10-19 | 주식회사 로노 | Composition de rajeunissement de cellules sénescentes ou de retardement ou de prévention du vieillissement cellulaire |
CN116640727B (zh) * | 2023-07-26 | 2023-09-22 | 成都高新绮澳医疗美容诊所有限公司 | 一种提高细胞活力的营养液及其制备方法、应用 |
CN117159588B (zh) * | 2023-11-01 | 2024-02-13 | 北京国卫生物科技有限公司 | 脐带间充质干细胞治疗骨关节炎的细胞治疗方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110105393A1 (en) * | 2007-08-16 | 2011-05-05 | Andreas Androutsellis-Theotokis | Methods for promoting stem cell proliferation and survival |
WO2009042798A1 (fr) * | 2007-09-26 | 2009-04-02 | Cold Spring Harbor Laboratory | Procédés de traitement d'une fibrose par modulation de la sénescence cellulaire |
US10035834B2 (en) * | 2008-06-18 | 2018-07-31 | The Texas A&M University System | Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage |
WO2009155583A1 (fr) * | 2008-06-19 | 2009-12-23 | The Trustees Of The University Of Pennsylvania | Biomatériaux pour le remplacement de tissus |
WO2010065567A2 (fr) * | 2008-12-01 | 2010-06-10 | Lifespan Extension Llc | Procédés et compositions pour modifier la santé, le bien-être et l'espérance de vie |
JP2012143158A (ja) * | 2009-05-12 | 2012-08-02 | Hiroshima Univ | 誘導性間葉系幹細胞およびその作製方法 |
WO2011159726A2 (fr) * | 2010-06-14 | 2011-12-22 | The Scripps Research Institute | Reprogrammation de cellules pour leur conférer un nouveau destin |
WO2012006577A2 (fr) * | 2010-07-08 | 2012-01-12 | Duke University | Reprogrammation directe de cellules en un devenir de cardiomyocytes |
KR101737164B1 (ko) * | 2010-11-12 | 2017-05-17 | 알러간, 인코포레이티드 | 물질대사된 조건화 성장 배지 및 이용 방법 |
WO2014013014A1 (fr) * | 2012-07-18 | 2014-01-23 | Fundació Privada Centre De Regulació Genòmica (Crg) | Inhibiteurs de jak pour l'activation de populations de cellules souches épidermiques |
WO2014089121A2 (fr) * | 2012-12-03 | 2014-06-12 | Thomas Ichim | Administration rétrograde de cellules et d'acides nucléiques pour le traitement de maladies cardiovasculaires |
WO2015056804A1 (fr) * | 2013-10-17 | 2015-04-23 | 国立大学法人京都大学 | Procédé efficace pour l'établissement de cellules souches pluripotentes induites |
WO2016027099A2 (fr) * | 2014-08-22 | 2016-02-25 | Cambridge Enterprise Limited | Réinitialisation de cellules souches pluripotentes |
CN105441384B (zh) * | 2014-09-26 | 2021-01-05 | 北京大学 | 一种制备动物和人类原始多潜能干细胞的方法,试剂盒及用途 |
CN106337037A (zh) * | 2015-07-08 | 2017-01-18 | 中国科学院上海生命科学研究院 | 一种诱导成纤维细胞直接向神经细胞转化的药物组合物及其用途 |
CN105169487A (zh) * | 2015-10-27 | 2015-12-23 | 上海交通大学 | 一种具有生物活性的创面修复细胞膜片、制备方法及应用 |
US20180360924A1 (en) * | 2015-11-25 | 2018-12-20 | The Methodist Hospital System | Telomere extension and anti-inflammatory agents for cell regeneration |
WO2017091943A1 (fr) * | 2015-11-30 | 2017-06-08 | Hong Guan Ltd. | Procédés améliorés de reprogrammation de cellules non-pluripotentes en cellules souches pluripotentes |
US20200080050A1 (en) * | 2016-07-11 | 2020-03-12 | Yaakov Nahmias | Systems and methods for growing cells in vitro |
US20180055887A1 (en) * | 2016-08-23 | 2018-03-01 | Academia Sinica | Method for preparing induced mesenchymal stem cells and improving mesenchymal stem cell's characters and its applications |
CN108060120B (zh) * | 2016-11-07 | 2022-11-04 | 云南济慈再生医学研究院有限公司 | 用于分化的细胞重编程的小分子化合物组合、试剂盒及应用 |
CN108060119B (zh) * | 2016-11-07 | 2021-07-09 | 云南济慈再生医学研究院有限公司 | 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备血管平滑肌细胞的方法 |
CN108060123B (zh) * | 2016-11-07 | 2021-07-09 | 云南济慈再生医学研究院有限公司 | 一种用于体细胞去分化的靶点调控系统、试剂盒及应用 |
CN108060122B (zh) * | 2016-11-07 | 2021-07-09 | 深圳臻德济慈药品研发有限公司 | 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备软骨细胞的方法 |
CN108060126B (zh) * | 2016-11-07 | 2020-09-08 | 云南济慈再生医学研究院有限公司 | 一种诱导分化的细胞制备间充质干细胞的方法及调控靶点的组合 |
CN108300686B (zh) * | 2017-01-13 | 2022-08-26 | 云南美颜美龄生物科技有限公司 | 用于预防、延缓或逆转细胞、组织、器官、机体衰老的小分子化合物/组合,产品及其用途 |
CN110218696A (zh) * | 2018-03-01 | 2019-09-10 | 中国科学院广州生物医药与健康研究院 | 一种用于化学诱导多能性干细胞生成的培养体系以及使用该培养体系的化学重编程方法 |
CN112567020A (zh) * | 2018-03-06 | 2021-03-26 | 埃皮博恩股份有限公司 | 可注射的即用的软骨、肌腱和韧带修复组合物及其使用方法 |
JP7419347B2 (ja) * | 2018-04-23 | 2024-01-22 | エイジェックス・セラピューティクス・インコーポレイテッド | 哺乳動物細胞における組織再生の誘導及びセノリシスのための改良された方法 |
CN110423721B (zh) * | 2018-05-01 | 2024-02-27 | 云南济慈再生医学研究院有限公司 | 一种年轻化的修复型成纤维细胞的制备方法及其应用 |
CN117887659A (zh) * | 2018-05-01 | 2024-04-16 | 云南济慈再生医学研究院有限公司 | 一种促进靶细胞向神经细胞分化的方法 |
WO2019213796A1 (fr) * | 2018-05-05 | 2019-11-14 | The Regents Of The University Of California | Cellules souches mésenchymateuses régénérées induites et leurs procédés d'utilisation |
CN110408594A (zh) * | 2019-07-31 | 2019-11-05 | 吉林大学 | 一种将人成纤维细胞高效大量重编程为成熟神经元的方法 |
CN113025562B (zh) * | 2021-03-18 | 2022-11-29 | 浙江大学 | R406在促进体细胞重编程中的应用、其重编程培养基及方法 |
US20220296645A1 (en) * | 2021-03-22 | 2022-09-22 | Spiritus Therapeutics, Inc. | Diagnostic and therapeutic uses of compositions comprising purified, enriched potent exosomes containing disease-based and therapy based signature cargo |
-
2018
- 2018-05-01 CN CN201810407290.XA patent/CN110423721B/zh active Active
-
2019
- 2019-05-01 CA CA3098938A patent/CA3098938C/fr active Active
- 2019-05-01 WO PCT/CN2019/085401 patent/WO2019210870A1/fr unknown
- 2019-05-01 AU AU2019263866A patent/AU2019263866B2/en active Active
- 2019-05-01 SG SG11202010857TA patent/SG11202010857TA/en unknown
- 2019-05-01 EP EP19795824.2A patent/EP3789484A4/fr active Pending
- 2019-05-01 JP JP2021510512A patent/JP2021523734A/ja active Pending
-
2020
- 2020-10-31 US US17/086,397 patent/US20210213069A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2021523734A (ja) | 2021-09-09 |
AU2019263866A1 (en) | 2020-11-26 |
CA3098938A1 (fr) | 2019-11-07 |
CN110423721B (zh) | 2024-02-27 |
AU2019263866B2 (en) | 2023-03-30 |
EP3789484A4 (fr) | 2022-01-05 |
CA3098938C (fr) | 2023-12-05 |
CN110423721A (zh) | 2019-11-08 |
EP3789484A1 (fr) | 2021-03-10 |
US20210213069A1 (en) | 2021-07-15 |
WO2019210870A1 (fr) | 2019-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202010857TA (en) | Preparation method for rejuvenated regenerative fibroblast and application thereof | |
HK1254685A1 (zh) | 一種改善轉粘的彩妝組合物及其製備方法 | |
IL258288B (en) | Hair strengthening compound and hair strengthening method | |
IL263439A (en) | Composition and method for reducing neutropenia | |
GB201905559D0 (en) | Composition and method | |
EP3517144A4 (fr) | Composition pour la régénération du cartilage et son procédé de préparation | |
EP3733650A4 (fr) | Procédé de préparation d'un intermédiaire d'élagolix et composition associée | |
EP3587375A4 (fr) | Composition de béton et son procédé de préparation | |
ZA202107279B (en) | Catalytic-cracking catalyst and method for preparation thereof | |
IL276244A (en) | A pharmaceutical preparation for the eyes, a method for its preparation and its application | |
GB201909542D0 (en) | Composition and method | |
EP3600344A4 (fr) | Compositions et méthodes de régénération cardiaque | |
ZA201908090B (en) | Pharmaceutical composition and method for preparing same | |
SG11201705265RA (en) | Composition for forming underlayer and method for forming underlayer therewith | |
ZA201800959B (en) | Methods and formulations for reducing bovine emissions | |
EP3674376A4 (fr) | Composition d'électrodéposition cationique et procédé d'électrodéposition | |
EP3685980A4 (fr) | Agent nettoyant pour le nettoyage d'une machine à mouler et procédé de nettoyage | |
HK1248136A1 (zh) | 用於治療目的的板層小體的組合物和方法 | |
GB201619802D0 (en) | Agents and method for the temporary shaping of keratin-containing fibers | |
HK1257196A1 (zh) | 組合物及其製備方法、應用 | |
PL3846637T3 (pl) | Kompozycja maceratu i sposób jej wytwarzania | |
GB201818328D0 (en) | Method and composition | |
GB201817000D0 (en) | Method and composition | |
GB201805951D0 (en) | Pharmaceutical composition and method for manufacturing the same | |
GB201800877D0 (en) | Method and composition |